Conversion of Astrocytes and Fibroblasts into Functional Noradrenergic Neurons
Author(s) -
Sanlan Li,
Yuhan Shi,
Xuan Yao,
Xing Wang,
Libing Shen,
Zhiping Rao,
Jiacheng Yuan,
Yueguang Liu,
Zhenning Zhou,
Ziheng Zhang,
Fei Liu,
Sue Han,
Junlan Geng,
Hui Yang,
Leping Cheng
Publication year - 2019
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2019.06.042
Subject(s) - reprogramming , biology , neuroscience , neuron , microbiology and biotechnology , transplantation , biological neural network , induced pluripotent stem cell , astrocyte , transcription factor , cell , embryonic stem cell , gene , medicine , central nervous system , genetics
Dysfunction of noradrenergic (NA) neurons is associated with a number of neuronal disorders. Diverse neuronal subtypes can be generated by direct reprogramming. However, it is still unknown how to convert non-neuronal cells into NA neurons. Here, we show that seven transcription factors (TFs) (Ascl1, Phox2b, AP-2α, Gata3, Hand2, Nurr1, and Phox2a) are able to convert astrocytes and fibroblasts into induced NA (iNA) neurons. These iNA neurons express the genes required for the biosynthesis, release, and re-uptake of noradrenaline. Moreover, iNA neurons fire action potentials, receive synaptic inputs, and control the beating rate of co-cultured ventricular myocytes. Furthermore, iNA neurons survive and integrate into neural circuits after transplantation. Last, human fibroblasts can be converted into functional iNA neurons as well. Together, iNA neurons are generated by direct reprogramming, and they could be potentially useful for disease modeling and cell-based therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom